Clinical trial
A Randomized Controlled Trial on the Effect of Hydroxychloroquine in Mild Graves' Orbitopathy
NCT05126147 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial on the Effect of Hydroxychloroquine in Mild Graves' Orbitopathy
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 21, 2022
- Completion date
- December 31, 2026
- Enrollment
- 108 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.